GARDEN OF LIFE 4200 Northcorp ParkwayPalm Beach Gardens, FL 33410

DescriptionLot NumberCategory (Type)Received

AnalysisInstrumentMethodAnalysis Date

Reported byAnresco, Inc.

November 05, 2019

Limit of Quantitation: 1.0 mg/g Limit of Detection: 0.4 mg/g ND = None Detected<LOQ = Below Limit of Quantitation<LOD = Below Limit of Detection

November 05, 2019

Order No. 509497 Sample No. 1037380

SAMPLE INFORMATION6913 Dr. Formulated CBD + Sleep 15 mgW2909932 19302ConcentrateOctober 31, 2019

ANALYTICAL RESULTSCannabinoid Profile PassLiquid Chromatography Diode Array Detector (LC-DAD)MF12D012October 31, 2019 to November 05, 2019

Analyte mg/g % mg/ml mg/serving mg/package StatusTotal THC ND ND ND ND ND PassTotal CBD 16.646 1.6646 15.7138 15.7138 471.41 -

Label Claims n/pMeasured Serving Weight (g) 0.94400Servings / Unit 30 g/ml Conversion Factor 0.94400

✔

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

1 1

GARDEN OF LIFE 4200 Northcorp ParkwayPalm Beach Gardens, FL 33410

DescriptionLot NumberCategory (Type)Received

AnalysisInstrumentMethodAnalysis Date

Reported byAnresco, Inc.

November 05, 2019

Limit of Detection: 0.0005 mg/g Limit of Quantitation: 0.0015 mg/g ND = None Detected<LOQ = Below Limit of Quantitation<LOD = Below Limit of Detection

November 05, 2019

Order No. 509497 Sample No. 1037380

SAMPLE INFORMATION6913 Dr. Formulated CBD + Sleep 15 mgW2909932 19302ConcentrateOctober 31, 2019

ANALYTICAL RESULTSTerpene Profile Gas Chromatography Mass Spectrometry (GC/MS)American Herbal PharmacopoeiaOctober 31, 2019 to November 05, 2019

Terpene mg/g % Statusα-Pinene 0.0845 0.00845 -Isopulegol ND ND -Camphene <LOQ <LOQ -Menthol ND ND -ß-Myrcene 0.0514 0.00514 -(-)-Borneol 0.0169 0.00169 -β-Pinene <LOQ <LOQ -Terpineol <LOQ <LOQ -δ -3-Carene ND ND -Citronellol <LOQ <LOQ -Limonene 1.95 0.195 -Geraniol <LOQ <LOQ -α-Terpinene <LOQ <LOQ -ß-Caryophyllene 0.0552 0.00552 -trans-beta-Ocimene 0.0196 0.00196 -α-Humulene <LOQ <LOQ -cis-beta-Ocimene 0.0378 0.00378 -cis-Nerolidol ND ND -p-Cymene ND ND -trans-Nerolidol <LOQ <LOQ -Eucalyptol 0.078 0.00780 -Guaiol <LOQ <LOQ -γ-Terpinene <LOQ <LOQ -Caryophyllene Oxide <LOQ <LOQ -Terpinolene <LOQ <LOQ -α-Bisabolol <LOQ <LOQ -Linalool 0.405 0.0405 -Eudesmol <LOQ <LOQ -

Total Terpenes 2.6984 0.26984 -

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

1 1

GARDEN OF LIFE 4200 Northcorp ParkwayPalm Beach Gardens, FL 33410

DescriptionLot NumberCategory (Type)Received

Analysis Date

Reported byAnresco, Inc.

November 07, 2019

Order No. 509497 Sample No. 1037380

SAMPLE INFORMATION6913 Dr. Formulated CBD + Sleep 15 mgW2909932 19302ConcentrateOctober 31, 2019

ANALYTICAL RESULTSOctober 31, 2019 to November 07, 2019

Analysis Method FindingsColiforms FDA BAM - ECC Agar <10 E. Coli FDA BAM - ECC Agar <10 Mold FDA BAM <10 Salmonella AOAC 2016.01 Negative/1g Standard Plate Count FDA BAM <10 Staph AOAC 2003.07 <10 Yeast FDA BAM <10

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

1 1

GARDEN OF LIFE 4200 Northcorp ParkwayPalm Beach Gardens, FL 33410

DescriptionLot NumberCategory (Type)Received

AnalysisInstrumentMethodAnalysis Date

Reported byAnresco, Inc.

November 05, 2019

ND = None Detected<LOQ = Below Limit of Quantitation<LOD = Below Limit of Detection

November 05, 2019

Order No. 509497 Sample No. 1037380

SAMPLE INFORMATION6913 Dr. Formulated CBD + Sleep 15 mgW2909932 19302ConcentrateOctober 31, 2019

ANALYTICAL RESULTS

Heavy Metal Screen PassICP-MSMF 24E020October 31, 2019 to November 05, 2019

Analyte LOD / LOQ (µg/g) Findings (µg/g) Limit (µg/g) StatusArsenic 0.02/0.05 ND 1.5 PassCadmium 0.02/0.05 ND 0.5 PassLead 0.02/0.05 ND 0.5 PassMercury 0.02/0.05 ND 3.0 Pass

✔

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

1 1

GARDEN OF LIFE 4200 Northcorp ParkwayPalm Beach Gardens, FL 33410

DescriptionLot NumberCategory (Type)Received

AnalysisInstrumentMethodAnalysis Date

Reported byAnresco, Inc.

November 05, 2019

ND = None Detected<LOQ = Below Limit of Quantitation<LOD = Below Limit of Detection

November 05, 2019

Order No. 509497 Sample No. 1037380

SAMPLE INFORMATION6913 Dr. Formulated CBD + Sleep 15 mgW2909932 19302ConcentrateOctober 31, 2019

ANALYTICAL RESULTSResidual Solvent Screen PassGas Chromatography Mass Spectrometry (GC/MS)USP OVI<467>October 31, 2019 to November 05, 2019

Analyte LOD / LOQ (µg/g) Findings (µg/g) Limit (µg/g) Status1,2-Dichloroethane 0.40/1.00 ND 1.0 PassAcetone 17/75 ND 5000 PassAcetonitrile 1/6 ND 410 PassBenzene 0.40/1.00 ND 1.0 Passn-Butane 200/600 ND 5000 PassChloroform 0.40/1.00 ND 1.0 PassEthanol 22/100 ND 5000 PassEthyl Acetate 9/40 ND 5000 PassEthyl Ether 11/50 ND 5000 PassEthylene Oxide 0.40/1.00 ND 1.0 Passn-Heptane 11/50 ND 5000 Passn-Hexane 1/5 ND 290 PassIsopropyl Alcohol 11/50 ND 5000 PassMethanol 6/25 ND 3000 PassMethylene Chloride 0.40/1.00 ND 1.0 Passn-Pentane 17/75 ND 5000 PassPropane 125/250 ND 5000 PassToluene 3/15 ND 890 PassTotal Xylenes 1/3 ND 2170 PassTrichloroethylene 0.40/1.00 ND 1.0 Pass

✔

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

1 1

GARDEN OF LIFE 4200 Northcorp ParkwayPalm Beach Gardens, FL 33410

DescriptionLot NumberCategory (Type)Received

YEFEAFA: [1] November 05, 2019

Order No. 509497 Sample No. 1037380

SAMPLE INFORMATION

6913 Dr. Formulated CBD + Sleep 15 mgW2909932 19302ConcentrateOctober 31, 2019

ANALYTICAL RESULTS

Analysis Pesticide Residue Screen Pass Instrument Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) & Gas Chromatography

Tandem Mass Spectrometry (GC-MS/MS)Method MF 21P030Analysis Date October 31, 2019 to November 05, 2019

Analyte LOD / LOQ (µg/g) Findings (µg/g) Limit (µg/g) StatusAbamectin 0.04/0.10 ND 0.3 Pass Azoxystrobin 0.04/0.10 ND 40.0 Pass Bifenazate 0.04/0.10 ND 5.0 Pass Bifenthrin 0.20/0.50 ND 0.5 Pass Cyfluthrin 0.70/2.00 ND 1.0 Pass Daminozide 0.04/0.10 ND 0.04 Pass Etoxazole 0.04/0.10 ND 1.5 Pass Fenoxycarb 0.04/0.10 ND 0.04 Pass Imazalil 0.04/0.10 ND 0.04 Pass Imidacloprid 0.04/0.10 ND 3.0 Pass Myclobutanil 0.04/0.10 ND 9.0 Pass Paclobutrazol 0.04/0.10 ND 0.04 Pass Piperonyl Butoxide 0.04/0.10 ND 8.0 Pass Pyrethrins 0.20/0.50 ND 1.0 Pass Spinosad 0.04/0.10 ND 3.0 Pass Spiromesifen 0.04/0.10 ND 12.0 Pass Spirotetramat 0.04/0.10 ND 13.0 Pass Trifloxystrobin 0.04/0.10 ND 30.0 Pass

✔

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

1 2

Reported byAnresco, Inc.

November 05, 2019

ND = None Detected<LOQ = Below Limit of Quantitation<LOD = Below Limit of Detection

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

2 2

GARDEN OF LIFE 4200 Northcorp ParkwayPalm Beach Gardens, FL 33410

DescriptionLot NumberCategory (Type)Received

Analysis Date

November 05, 2019

Order No. 509497 Sample No. 1037380

SAMPLE INFORMATION6913 Dr. Formulated CBD + Sleep 15 mgW2909932 19302ConcentrateOctober 31, 2019

ANALYTICAL RESULTS

October 31, 2019 to November 05, 2019

Analyte LOD / LOQ Finding UnitsGluten 5/5 ND ppm

Reported byAnresco, Inc.

November 05, 2019

If there are any questions with this report, please contact "compliance@anresco.com". page of

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave,. San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.

1 1

HEAVY METAL SCREEN Pass 09/25/2019

MYCOTOXIN SCREEN Pass 09/24/2019

OTHER ANALYSES

(-) = Not Tested, ND = None Detected, <LOQ = Below Limit of Quantitation, LOD = Limit of Detection

Scan to verify

Method: MF 24E020

Instrument: ICP-MS

Analyte LOD / LOQ (µg/g) Finding (µg/g) Limit (µg/g) StatusArsenic 0.02/0.05 ND 0.2 PassCadmium 0.02/0.05 ND 0.2 PassMercury 0.02/0.05 ND 0.1 PassLead 0.02/0.05 <LOQ 0.5 Pass

Method: MF 21P030

Instrument: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) & Gas Chromatography Tandem Mass Spectrometry (GC-MS/MS)

Analyte LOD / LOQ (µg/kg) Finding (µg/kg) Limit (µg/kg) StatusAflatoxin B1 10/20 ND - -Afalatoxin B2 10/20 ND - -Aflatoxin G1 10/20 ND - -Aflatoxin G2 10/20 ND - -Total Aflatoxins 10/20 ND 20 PassOchratoxin A 10/20 ND 20 Pass

Analyte Method Instrument Finding LOD LOQ Units Date Completed Limit StatusMoisture 'AOAC 930.04' Vacuum or Forced Air Oven 0.93 - - - 09/23/2019 - -Water Activity MF 14G051 Decagon 0.571 - - - 09/23/2019 0.65 PassGluten - - ND - - - 09/24/2019 - -Color - - Amber - - - 09/24/2019 - -Flavor - - Grassy - - - 09/24/2019 - -Odor - - Piney - - - 09/24/2019 - -Glyphosate Anresco MF 2P030 LC-MS/MS ND 2 5 ppb 10/02/2019 - -AMPA Anresco MF 2P030 LC-MS/MS ND 2 5 ppb 10/02/2019 - -

Reported by

✔

✔

Sample #: 1034374 Batch #: PX-19211-NDT

Anresco Laboratories www.anresco.com Tel: 415 822 11001375 Van Dyke Ave, San Francisco, CA 94124 Fax: 415 822 6615

This document is intended only for the use of the party to whom it is addressed and may contain information that is privileged, confidential or protected from disclosureunder applicable law. If you have received this document in error, please immediately notify us and return it to the address listed above.